Literature DB >> 16291882

Non-invasive brain stimulation for Parkinson's disease: a systematic review and meta-analysis of the literature.

F Fregni1, D K Simon, A Wu, A Pascual-Leone.   

Abstract

A systematic review and meta-analysis were conducted to quantify the efficacy of transcranial magnetic stimulation (TMS) and electroconvulsive therapy (ECT) for the treatment of motor dysfunction in patients with Parkinson's disease (PD). Prospective studies which evaluated the effects of either TMS (12 studies) or ECT (five studies) on motor function in PD using the motor subscale of the Unified Parkinson's Disease Rating Scale (UPDRS) for TMS studies and any continuous measures of motor function in PD for ECT studies were included. The pooled effect size (standardised mean difference between pre-treatment versus post-treatment means) from a random effects model was 0.62 (95% confidence interval: 0.38, 0.85) for TMS treatment and 1.68 (0.79, 2.56) for ECT treatment, and from a fixed effects model was 0.59 (0.39, 0.78) for TMS treatment and 1.55 (1.07, 2.03) for ECT treatment. TMS, across applied stimulation sites and parameters, can exert a significant, albeit modest, positive effect on the motor function of patients with PD. ECT also may exert a significant effect on motor function in PD patients.

Entities:  

Mesh:

Year:  2005        PMID: 16291882      PMCID: PMC1739437          DOI: 10.1136/jnnp.2005.069849

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  58 in total

1.  Therapeutic effect and mechanism of repetitive transcranial magnetic stimulation in Parkinson's disease.

Authors:  H Shimamoto; K Takasaki; M Shigemori; T Imaizumi; M Ayabe; H Shoji
Journal:  J Neurol       Date:  2001-09       Impact factor: 4.849

2.  ECT and delirium in Parkinson's disease.

Authors:  I M Zervas; M Fink
Journal:  Am J Psychiatry       Date:  1992-12       Impact factor: 18.112

3.  Clinical effects of repetitive transcranial magnetic stimulation versus acute levodopa challenge in Parkinson's disease.

Authors:  Ch Börnke; T Schulte; H Przuntek; Th Müller
Journal:  J Neural Transm Suppl       Date:  2004

4.  Improved picture naming in chronic aphasia after TMS to part of right Broca's area: an open-protocol study.

Authors:  Margaret A Naeser; Paula I Martin; Marjorie Nicholas; Errol H Baker; Heidi Seekins; Masahito Kobayashi; Hugo Theoret; Felipe Fregni; Jose Maria-Tormos; Jacquie Kurland; Karl W Doron; Alvaro Pascual-Leone
Journal:  Brain Lang       Date:  2005-04       Impact factor: 2.381

5.  Can left prefrontal rTMS be used as a maintenance treatment for bipolar depression?

Authors:  Xingbao Li; Ziad Nahas; Berry Anderson; F Andrew Kozel; Mark S George
Journal:  Depress Anxiety       Date:  2004       Impact factor: 6.505

6.  ECT in Parkinson's disease: neuropsychological response.

Authors:  S Pridmore; A Lowrie; G Holmes; C Pollard
Journal:  Convuls Ther       Date:  1996-12

7.  A double-blind evaluation of electroconvulsive therapy in Parkinson's disease with "on-off" phenomena.

Authors:  K Andersen; J Balldin; C G Gottfries; A K Granérus; K Modigh; L Svennerholm; A Wallin
Journal:  Acta Neurol Scand       Date:  1987-09       Impact factor: 3.209

8.  Transcranial magnetic stimulation accelerates the antidepressant effect of amitriptyline in severe depression: a double-blind placebo-controlled study.

Authors:  Demetrio Ortega Rumi; Wagner F Gattaz; Sergio Paulo Rigonatti; Moacyr Alexandro Rosa; Felipe Fregni; Marina Odebrecht Rosa; Carlos Mansur; Martin Luiz Myczkowski; Ricardo Alberto Moreno; Marco Antonio Marcolin
Journal:  Biol Psychiatry       Date:  2005-01-15       Impact factor: 13.382

9.  Sustained excitability elevations induced by transcranial DC motor cortex stimulation in humans.

Authors:  M A Nitsche; W Paulus
Journal:  Neurology       Date:  2001-11-27       Impact factor: 9.910

10.  Therapeutic efficacy of bilateral prefrontal slow repetitive transcranial magnetic stimulation in depressed patients with Parkinson's disease: an open study.

Authors:  Natasa Dragasevic; Aleksandra Potrebić; Aleksandar Damjanović; Elka Stefanova; Vladimir S Kostić
Journal:  Mov Disord       Date:  2002-05       Impact factor: 10.338

View more
  71 in total

1.  Treatment frontiers.

Authors:  Kerri Smith
Journal:  Nature       Date:  2010-08-26       Impact factor: 49.962

2.  Transcranial direct current stimulation in patients with skull defects and skull plates: high-resolution computational FEM study of factors altering cortical current flow.

Authors:  Abhishek Datta; Marom Bikson; Felipe Fregni
Journal:  Neuroimage       Date:  2010-05-07       Impact factor: 6.556

Review 3.  Repetitive Transcranial Magnetic Stimulation (rTMS) Therapy in Parkinson Disease: A Meta-Analysis.

Authors:  Aparna Wagle Shukla; Jonathan J Shuster; Jae Woo Chung; David E Vaillancourt; Carolynn Patten; Jill Ostrem; Michael S Okun
Journal:  PM R       Date:  2015-08-24       Impact factor: 2.298

4.  Controlled study of 50-Hz repetitive transcranial magnetic stimulation for the treatment of Parkinson disease.

Authors:  David H Benninger; Kazumi Iseki; Sarah Kranick; David A Luckenbaugh; Elise Houdayer; Mark Hallett
Journal:  Neurorehabil Neural Repair       Date:  2012-05-15       Impact factor: 3.919

Review 5.  Recognition and management of neuropsychiatric complications in Parkinson's disease.

Authors:  Florian Ferreri; Catherine Agbokou; Serge Gauthier
Journal:  CMAJ       Date:  2006-12-05       Impact factor: 8.262

6.  Transcranial direct current stimulation for the treatment of Parkinson's disease.

Authors:  David H Benninger; Mikhail Lomarev; Grisel Lopez; Eric M Wassermann; Xiaobai Li; Elaine Considine; Mark Hallett
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-10       Impact factor: 10.154

Review 7.  Use of transcranial magnetic stimulation to influence behavior.

Authors:  Benzi M Kluger; William J Triggs
Journal:  Curr Neurol Neurosci Rep       Date:  2007-11       Impact factor: 5.081

Review 8.  The role of neuroplasticity in dopaminergic therapy for Parkinson disease.

Authors:  Xiaoxi Zhuang; Pietro Mazzoni; Un Jung Kang
Journal:  Nat Rev Neurol       Date:  2013-04-16       Impact factor: 42.937

9.  Motor intracortical inhibition in PD: L-DOPA modulation of high-frequency rTMS effects.

Authors:  Brigida Fierro; Filippo Brighina; Marco D'Amelio; Ornella Daniele; Innocenzo Lupo; Paolo Ragonese; Antonio Palermo; Giovanni Savettieri
Journal:  Exp Brain Res       Date:  2007-09-08       Impact factor: 1.972

10.  Cerebral cortex plasticity after 90 days of bed rest: data from TMS and fMRI.

Authors:  Donna R Roberts; David Ramsey; Kevin Johnson; Jejo Kola; Raffaella Ricci; Christian Hicks; Jeffrey J Borckardt; Jacob J Bloomberg; Charles Epstein; Mark S George
Journal:  Aviat Space Environ Med       Date:  2010-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.